Chairman
Caris Life Sciences, Inc. (CAI)Equibles does not estimate personal net worth.
Brian Brille is recorded as Chairman at Caris Life Sciences, Inc. (CAI). Brian Brille has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for Caris Life Sciences, Inc. on August 5, 2026. Caris Life Sciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Caris Life Sciences, Inc. includes David Dean Halbert (CEO), Jeffrey Vacirca (CEO), Brian J. Brille (Chairman) and 6 others.
“This is another strong quarter and we're pleased to report sustained growth, profitability, and cash generation, which supports our investment strategy focused on our MSED launch, the broader product pipeline, and commercial platform expansion.”
“I'm vice chairman of Keras Life Sciences. I'm here with Milan Radovich, our CSO, and Luke Power, our CFO.”
“This is our second call as a public company following our June IPO, and as David mentioned, we're pleased to report another record-breaking quarter, one that marks the significant milestone in CARES' history in terms of continued growth and underlying profitability.”
Biotechnology · Healthcare
Chairman
